Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06008613 · ClinicalTrials.gov registry record · NA
3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair
A NA study of Abdominal Aortic Aneurysm, sponsored by The Cleveland Clinic.
- Active
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT06008613 is a NA study of Abdominal Aortic Aneurysm that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 3 participants, below the 454-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06008613, a NA study of Abdominal Aortic Aneurysm, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an Early Feasibility Study to evaluate the usability, safety and functionality of 3D holographic guidance, navigation, and control (3D-GNC) as an adjunct to and confirmed by fluoroscopic imaging to be used with Cook Zenith Flex AAA Endovascular Graft.
Conditions Studied
Interventions
- DEVICE 3D Holographic Guidance, Navigation, and Control (3D GN&C)
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06008613
The ClinicalTrials.gov registry entry for NCT06008613 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (99% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which 3D Holographic Guidance, Navigation, and Control (3D GN&C) is the first listed.
NCT06008613 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06008613 about?
NCT06008613 is a clinical study titled "3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair". This is an Early Feasibility Study to evaluate the usability, safety and functionality of 3D holographic guidance, navigation, and control (3D-GNC) as an adjunct to and confirmed by fluoroscopic imaging to be used with Cook Zenith Flex AAA Endovascular Graft.
What is the current status of trial NCT06008613?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2023-10-18. Estimated completion is 2025-12-31.
What conditions does trial NCT06008613 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.
What interventions are being tested in trial NCT06008613?
The interventions under investigation include: 3D Holographic Guidance, Navigation, and Control (3D GN&C) (DEVICE).
Who is sponsoring clinical trial NCT06008613?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06008613 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques
RECRUITING · NA
-
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
RECRUITING · NA
-
Post-Approval Study of the TREO Abdominal Stent-Graft System
ACTIVE NOT RECRUITING · NA
-
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
COMPLETED · NA
-
Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.